WKWerner J. H. Koopman

Werner J. H. Koopman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Werner J. H. Koopman has a total of 297 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    NAD + or β-hydroxybutyrate each protects against tachypacing-induced metabolic remodeling through regulation of mitophagy in HL-1 cardiomyocytes

    by Xi Qi, Liangyu Hu, Alexia van Rinsum, Werner J. H. Koopman, Jaap Keijer, Deli Zhang

    Nicotinamide adenine dinucleotide and β-hydroxybutyrate restore mitochondrial function and metabolic balance, in part by preserving PINK1-Parkin-MFN2-mediated mitophagy. Silencing key mitophagy regulators abolishes these protective effects, identifying mitophagy as a central mechanism linking metabolic interventions to functional recovery and as a potential therapeutic target in atrial fibrillation-associated remodeling.


  • Open Access

    Leigh Syndrome Pathomechanism Involves Region-Specific Innate Immune Activation in Ndufs4 Knockout Mice

    by Belinda R. Fouché, Sibonelo G. Khumalo, Werner J. H. Koopman, Marianne Venter

    Although recent evidence suggests that the immune system contributes to the pathogenesis of paediatric Leigh syndrome, detailed mechanistic insights are still lacking. Here, we investigated the involvement of immune system activation and inflammation in brain tissue in Leigh syndrome, using hypothesis generating methods. We compared the transcriptomes of olfactory bulb and cerebellum from male Ndufs4−/− (knockout) mice (n = 5–6), a well-established model of paediatric Leigh syndrome. Relative to wildtype animals, knockout mice displayed enrichment of innate immune system pathways in the olfactory bulb. Unexpectedly, relative to the olfactory bulb, few pathways were enriched in the cerebellum, and none that indicated similar changes to the immune system. Innate immune system pathways in the olfactory bulb were mainly upregulated and included a large set of interferon stimulated genes, and genes involved in JAK-STAT and retinoic acid-inducible gene 1-like signalling, interleukins, interferon receptors and endogenous double strand RNA sensors. We propose that innate immune system activation starts in the olfactory bulb, is mediated by the retinoic acid-inducible gene 1-like signalling pathway in response to increased cytosolic double-strand RNA, leading to chemokines that recruit leukocytes to other brain regions to elicit an immune response. Our results fill in the gap between mitochondrial dysfunction and activation of the innate immune response, which has been reported by others. Our findings strongly suggest that immune system activation constitutes part of the Leigh syndrome pathomechanism, which is compatible with the improvement observed in mitochondrial disease patients following immune system-targeting interventions. Graphical Abstract Enrichment of innate immune system pathways in olfactory bulb, but not cerebellum of Ndufs4−/− mice. Transcriptomic analysis of Ndufs4−/− mice brain tissues reveals enrichment of JAK-STAT and RIG-I-like receptor signalling pathways in olfactory bulb. We propose a pathomechanism of Leigh syndrome which starts with endogenous dsRNA molecules activating these signalling pathways, leading to chemokines that recruit leukocytes to other brain regions to elicit an immune response. Figure created with BioRender


  • Open Access

    The influence of cellular energy status, microtubules, and crowding on mitochondrial motion

    by Beatrice Corci, Werner J. H. Koopman, Amalia M. Dolga, Christoffer Åberg

    Mitochondrial motion in mammalian cells is affected by perturbation of cell energy, the microtubule network and cytoplasmic crowding in different ways, but prolongation of the time that mitochondria stall before longer movements is a main effect.


  • Open Access

    Increased ambient temperature mitigates pathology in the Ndufs4 -/- mouse model of pediatric Leigh Syndrome

    by Melissa A.E. van de Wal, Christian J.M.I. Klein, Merel J.W. Adjobo-Hermans, Els M.A. van de Westerlo, Clara van Karnebeek, Mirian C.H. Janssen, Jan. C. van der Meijden, Judith R. Homberg, Jaap Keijer, Evert M. van Schothorst, et al.

    Leigh syndrome (LS) is a devastating mitochondrial disease (MD) for which there is no treatment. Together with Leigh-like syndrome (LLS), LS constitutes part of the Leigh syndrome spectrum (LSS) disorders, which are the most frequent manifestation of a primary mitochondrial disease (MD) in children. Ndufs4 -/- mice are a widely used animal model to study LS pathophysiology and interventions. These mice display an isolated mitochondrial complex I deficiency and a brain-specific pathomechanism. Similar to other mouse models of human disease, Ndufs4 -/- mice are routinely housed and studied at a sub-thermoneutral ambient temperature. This means that these mice experience chronic cold-stress, which potentially aggravates disease symptoms and reduces their translational value. Here, we provide evidence that housing Ndufs4 -/- mice at 26 °C instead of 20 °C increases their skin, core and brain temperature. At this higher temperature, Ndufs4 -/- mice displayed lower energy expenditure and, importantly, a longer lifespan, pathology reversal in specific brain regions, as well as increased voluntary locomotor activity. We conclude that ambient temperature is a previously overlooked but highly relevant disease modifier in Ndufs4 -/- mice. Given the reduced mitochondrial energy production and aberrant thermoregulation in LSS and other MD patients, our findings suggest that reducing energy requirements might be of therapeutic value and/or contribute to an improved quality of life in these patients. In a broader sense, our results advocate the use of (more) thermoneutral housing to evaluate pathomechanisms and intervention strategies in murine models of human disease. Significance: We conclude that ambient temperature is a previously overlooked but highly relevant disease modifier in Ndufs4 -/- mice. Given the reduced mitochondrial energy production and aberrant thermoregulation in LS and other MD patients, our findings suggest that reducing energy requirements might be of therapeutic value and/or contribute to an improved quality of life in these patients. In a broader sense, our results clearly demonstrate why it is essential to use a (more) thermoneutral housing to evaluate pathomechanisms and intervention strategies in translational research with murine models of human disease.

  • Open Access

    Pluripotent stem cell-based drug discovery uncovers sildenafil as a treatment for mitochondrial disease

    by Annika Zink, Dao-Fu Dai, Annika Wittich, Marie-Thérèse Henke, Giulia Pedrotti, Sonja Heiduschka, Guillem S. Aguilar, Tancredi Massimo Pentimalli, Christian Brueser, Sofia Notopoulou, et al.

    Mitochondrial disease encompasses inherited disorders affecting mitochondrial function. A severe and untreatable form of mitochondrial disease is Leigh syndrome (LS) causing psychomotor regression and metabolic crises. To accelerate drug discovery for LS, we screened a library of 5,632 repurposable compounds in induced pluripotent stem cell (iPSC)-derived neural progenitor cells (NPCs) from LS patients. We identified phosphodiesterase 5 inhibitors (PDE5i) as leads, and prioritized sildenafil due to its safety profile. Sildenafil restored pathways regulating nervous system development, enhanced neurite outgrowth in LS neurons, and mitigated abnormal calcium responses in LS brain organoids under metabolic stress. In a mouse model of LS, sildenafil extended the lifespan and ameliorated metabolic and encephalopathy phenotypes. Chronic off-label compassionate treatment with sildenafil in six LS patients showed improvements in motor function and resistance to metabolic crises. These findings highlight the potential of iPSC-driven drug discovery and position sildenafil as a promising candidate for mitochondrial diseases.


  • Open Access

    A novel and robust method for assessing mitochondrial (dys)function in healthy and diseased frozen cardiac tissue

    by Liangyu Hu, Alexia van Rinsum, Rocco Caliandro, Xi Qi, Shuxiu Fan, Xinyi Jiang, Jur Massop, Melissa Bekkenkamp-Grovenstein, Christiane Ott, Tilman Grune, et al.

    Cardiovascular diseases are often associated with impairment in mitochondrial function detected by reduced mitochondrial oxygen consumption using high-resolution respirometry. However, existing respirometry protocols are limited by the necessity for fresh tissue samples. This study developed a method with tailored substrate-inhibitor titration (TSIT) of mitochondrial electron transport complexes (ETC) to measure mitochondrial function in frozen cardiac samples using high-resolution respirometry. Briefly, acetyl-CoA was added to fuel the tricarboxylic acid (TCA) cycle for NADH production, enabling complex I (CI)-linked respiratory assessment. NADH was then added to measure maximum CI-linked respiratory capacity, followed by rotenone and succinate to assess complex II (CII)-linked respiratory capacity. TSIT detected mitochondrial functional differences between frozen atrial and ventricular tissue, with comparable results as measured in fresh samples. It also detected cardiac mitochondrial dysfunction across various (patho)physiological mouse models (including aging, ischemia reperfusion, obesity, and CI deficiency) as well as in frozen human donor samples, highlighting its clinical potential. Furthermore, we showed the first evidence for supercomplexes (SCs) formation between ETC-SCs and the TCA cycle metabolon, underpinning TSIT feasibility. In conclusion, we established a novel, robust, sensitive and translational method (TSIT) for assessing mitochondrial (dys)function in frozen cardiac samples from various species, enabling flexible analysis of mitochondrial function in both laboratory and clinical settings.

  • Mitochondrial Nicotinamide Nucleotide Transhydrogenase: Role in Energy Metabolism, Redox Homeostasis, and Cancer

    by Zhuohui Gan, Inge van der Stelt, Weiwei Li, Liangyu Hu, Jingyi Song, Sander Grefte, Els van de Westerlo, Deli Zhang, Evert M. van Schothorst, Hedi L. Claahsen-Van der Grinten, et al.

    Significance: Dimeric nicotinamide nucleotide transhydrogenase (NNT) is embedded in the mitochondrial inner membrane and couples the conversion of NADP + /NADH into NADPH/NAD + to mitochondrial matrix proton influx. NNT was implied in various cancers, but its physiological role and regulation still remain incompletely understood. Recent Advances: NNT function was analyzed by studying: (1) NNT gene mutations in human (adrenal) glucocorticoid deficiency 4 (GCCD4), (2) Nnt gene mutation in C57BL/6J mice, and (3) the effect of NNT knockdown/overexpression in (cancer) cells. In these three models, altered NNT function induced both common and differential aberrations. Critical Issues: Information on NNT protein expression in GCCD4 patients is still scarce. Moreover, NNT expression levels are tissue-specific in humans and mice and the functional consequences of NNT deficiency strongly depend on experimental conditions. In addition, data from intact cells and isolated mitochondria are often unsuited for direct comparison. This prevents a proper understanding of NNT-linked (patho)physiology in GCCD4 patients, C57BL/6J mice, and cancer (cell) models, which complicates translational comparison. Future Directions: Development of mice with conditional NNT deletion, cell-reprogramming-based adrenal (organoid) models harboring specific NNT mutations, and/or NNT-specific chemical inhibitors/activators would be useful. Moreover, live-cell analysis of NNT substrate levels and mitochondrial/cellular functioning with fluorescent reporter molecules might provide novel insights into the conditions under which NNT is active and how this activity links to other metabolic and signaling pathways. This would also allow a better dissection of local signaling and/or compartment-specific ( i.e., mitochondrial matrix, cytosol, nucleus) effects of NNT (dys)function in a cellular context. Antioxid. Redox Signal. 41, 927–956.


  • Mitochondrial Morphofunctional Profiling in Primary Human Skin Fibroblasts Using TMRM and Mitotracker Green Co-staining

    by Jesper M. M. Bergmans, Els M. A. van de Westerlo, Sander Grefte, Merel J. W. Adjobo-Hermans, Werner J. H. Koopman

    Mitochondrial morphology and membrane potential (Δψ) are important readouts of mitochondrial function. Integrated analysis of these parameters in living cells can be performed using fluorescent lipophilic cations, which enter cells and accumulate in the mitochondrial matrix in a Δψ-dependent manner. Here, we describe the use of tetramethylrhodamine methyl ester (TMRM) and Mitotracker Green FM (MG) for mitochondrial morphology and semiquantitative Δψ analysis in living primary human skin fibroblasts (PHSFs). Practically, we present an integrated protocol to quantify mitochondrial morphology parameters and signal intensity using epifluorescence microscopy of PHSFs co-stained with TMRM and MG. This approach performs best using large flat cells like PHSFs, which display a high mitochondria-specific fluorescence signal and are imaged at a relatively high (x40) magnification.


  • Open Access

    Ndufs4 knockout mice with isolated complex I deficiency engage a futile adaptive brain response

    by Melissa A.E. van de Wal, Cenna Doornbos, Janne M. Bibbe, Judith R. Homberg, Clara van Karnebeek, Martijn A. Huynen, Jaap Keijer, Evert M. van Schothorst, Peter A.C. 'T Hoen, Mirian C.H. Janssen, et al.


  • Open Access

    Performance of TMRM and Mitotrackers in mitochondrial morphofunctional analysis of primary human skin fibroblasts

    by Shruti Desai, Sander Grefte, Els van de Westerlo, Susette Lauwen, Angela Paters, Jochen H.M. Prehn, Zhuohui Gan, Jaap Keijer, Merel J.W. Adjobo-Hermans, Werner J.H. Koopman